FR2077297A1 - - Google Patents

Info

Publication number
FR2077297A1
FR2077297A1 FR7102188A FR7102188A FR2077297A1 FR 2077297 A1 FR2077297 A1 FR 2077297A1 FR 7102188 A FR7102188 A FR 7102188A FR 7102188 A FR7102188 A FR 7102188A FR 2077297 A1 FR2077297 A1 FR 2077297A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7102188A
Other languages
French (fr)
Other versions
FR2077297B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exploaterings TBF AB
Original Assignee
Exploaterings TBF AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exploaterings TBF AB filed Critical Exploaterings TBF AB
Publication of FR2077297A1 publication Critical patent/FR2077297A1/fr
Application granted granted Critical
Publication of FR2077297B1 publication Critical patent/FR2077297B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C12N11/087—Acrylic polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/06—Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
FR7102188A 1970-01-23 1971-01-22 Expired FR2077297B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7000843A SE394820B (en) 1970-01-23 1970-01-23 MAKE BULLY COOLANTLY BINDING TO A WATEROLO POLYMER COOLANTLY ACTIVATELY, AS AMINO ACIDS, PEPTIDES, PROTEINS, NUCLEOTIDES AND NUCLEIC ACIDS BY REACTION WITH AN SUCH POLY

Publications (2)

Publication Number Publication Date
FR2077297A1 true FR2077297A1 (en) 1971-10-22
FR2077297B1 FR2077297B1 (en) 1976-03-19

Family

ID=20257189

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7102188A Expired FR2077297B1 (en) 1970-01-23 1971-01-22

Country Status (7)

Country Link
JP (1) JPS5623588B1 (en)
CA (1) CA1000687A (en)
DE (1) DE2102514B2 (en)
FR (1) FR2077297B1 (en)
GB (1) GB1343703A (en)
NL (1) NL7100902A (en)
SE (1) SE394820B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2450263A1 (en) * 1979-02-28 1980-09-26 Dow Chemical Co Coupling protein to latex particles having epoxy gps. - for use in immunological analysis esp. pregnancy testing
EP0186523A2 (en) * 1984-12-28 1986-07-02 Genex Corporation Insolubilized biological material composites
EP0187391A2 (en) * 1985-01-04 1986-07-16 Ernst Prof. Dr. Bayer Graft polymers from cross-linked polymers and polyoxyethylene, their preparation and use
EP0264984A1 (en) * 1986-09-23 1988-04-27 Akzo N.V. Carrier material for use in chromatography or carrying out enzymatic reactions
US5278303A (en) * 1992-06-12 1994-01-11 University Of Toronto Innovations Foundation Polymer-supported solution synthesis of oligosaccharides
US5616698A (en) * 1994-01-10 1997-04-01 University Of Toronto Innovations Foundation Polymer-supported solution synthesis of oligosaccharides

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3844892A (en) * 1972-12-19 1974-10-29 Gulf Research Development Co Method of immobilizing enzymes
DE3344912A1 (en) * 1983-12-13 1985-06-20 Hoechst Ag, 6230 Frankfurt CROSSLINKED POLYMERISATES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
DE3827867A1 (en) * 1988-08-17 1990-02-22 Hoechst Ag METHOD FOR PRODUCING CYCLIC UREAS
US9180206B2 (en) * 2007-05-14 2015-11-10 Empire Technology Development Llc Pharmaceutical preparation and manufacturing method thereof
CN111965341B (en) * 2020-08-10 2023-04-11 武汉菲恩生物科技有限公司 Dextran-based HRP-goat anti-mouse IgG labeled antibody and preparation method thereof

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2450263A1 (en) * 1979-02-28 1980-09-26 Dow Chemical Co Coupling protein to latex particles having epoxy gps. - for use in immunological analysis esp. pregnancy testing
EP0186523A2 (en) * 1984-12-28 1986-07-02 Genex Corporation Insolubilized biological material composites
EP0186523A3 (en) * 1984-12-28 1988-05-04 Genex Corporation Insolubilized biological material composites
EP0187391A2 (en) * 1985-01-04 1986-07-16 Ernst Prof. Dr. Bayer Graft polymers from cross-linked polymers and polyoxyethylene, their preparation and use
EP0187391A3 (en) * 1985-01-04 1989-01-04 Ernst Prof. Dr. Bayer Graft polymers from cross-linked polymers and polyoxyethylene, their preparation and use
EP0264984A1 (en) * 1986-09-23 1988-04-27 Akzo N.V. Carrier material for use in chromatography or carrying out enzymatic reactions
US4882226A (en) * 1986-09-23 1989-11-21 Akzo N.V. Carrier material for use in chromatography or carrying out enzymatic reactions
US5278303A (en) * 1992-06-12 1994-01-11 University Of Toronto Innovations Foundation Polymer-supported solution synthesis of oligosaccharides
US5616698A (en) * 1994-01-10 1997-04-01 University Of Toronto Innovations Foundation Polymer-supported solution synthesis of oligosaccharides

Also Published As

Publication number Publication date
GB1343703A (en) 1974-01-16
CA1000687A (en) 1976-11-30
DE2102514A1 (en) 1971-07-29
FR2077297B1 (en) 1976-03-19
NL7100902A (en) 1971-07-27
JPS5623588B1 (en) 1981-06-01
SE394820B (en) 1977-07-11
DE2102514B2 (en) 1977-08-18

Similar Documents

Publication Publication Date Title
ATA96471A (en)
AU1146470A (en)
AU2044470A (en)
AU1473870A (en)
AU1326870A (en)
AU2085370A (en)
AU2017870A (en)
AU1833270A (en)
AU1716970A (en)
AU1517670A (en)
AU1336970A (en)
AU1591370A (en)
AU1083170A (en)
AU2144270A (en)
AU2131570A (en)
AU2130770A (en)
AU1247570A (en)
AU1328670A (en)
AU1235770A (en)
AU1343870A (en)
AU2130570A (en)
AU2119370A (en)
AU2115870A (en)
AU1581370A (en)
AU2112570A (en)